Cell & Gene Therapy Strategies and Solutions for mRNA Therapeutics and Personalized Medicines 05-23-2024 / Dr. Xiao Pan, Director of Platform R&D Dept. Learn More
Cell & Gene Therapy Unlocking Affordability: Cell Therapy Development Strategies to Expand Patient Access 03-28-2024 / Dr. Li Chen, Sr. Director, Biologics Discovery Dept. ProBio VHH is a novel modality in antibody based therapy. Its naturally generated single-domain structure makes it an ideal building block in cell therapy. Learn More
Cell & Gene Therapy mRNA One-stop Solution: Plasmid, Linearized DNA, IVT-mRNA, mRNA-LNP and QC sharing 09-05-2023 / Dr. Xiao Pan, Sr. Director, Platform R&D Dept. The production of mRNA therapeutics and vaccines is a complex process that begins with pDNA manufacturing and ends with fill and finish by using different delivery technologies. Learn More
Cell & Gene Therapy Integrated one-stop solution for mRNA CMC 03-28-2023 / Dr. Xiao Pan, Director of Platform R&D Dept., ProBio The production of mRNA therapeutics and vaccines is a complex process that begins with pDNA manufacturing and ends with fill and finish by using different delivery technologies. Currently, there are some mRNA candidates in late-stage trials or commercial Learn More
Cell & Gene Therapy Addressing analytical control challenges for different plasmid DNA products 11-30-2022 / Lauren Lu, Senior Director of QC Dept Addressing analytical control challenges for different plasmid DNA products Learn More
Cell & Gene Therapy Development and manufacturing Strategy for DNA Base Vaccine-Drug Candidates 11-01-2022 / Mark Wei Since the outbreaks of COVID-19, DNA vaccines are promising in the SARS-CoV-2 vaccine race although they have a new platform technology that was not previously available on the market for human use. Learn More
Cell & Gene Therapy Scalable AAV Manufacturing Strategies 07-14-2022 / Dr. Xiao Pan Since the approval of the product Luxtura® using AAV as a vector in 2017, more and more clinical trials have been carried out rapidly, and various early clinical trial projects for rare diseases and a wide range of indications .. Learn More
Cell & Gene Therapy Lentiviral vector manufacturing using suspension cell line 03-11-2021 / Dr. Mahmood Ali, Project Manager of Virus (R&D) Purification Process CGT has made a great breakthrough in the recent years, however the industry is facing challenges in developing stable and scalable manufacturing process for viral vectors. Learn More